Fortrea (FTRE) to Release Earnings on Tuesday

Fortrea (NASDAQ:FTRE) is expected to be releasing its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect Fortrea to post earnings of $0.03 per share and revenue of $627.42 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 8:00 AM ET.

Fortrea (NASDAQ:FTRE) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.07). The firm had revenue of $660.50 million for the quarter, compared to the consensus estimate of $665.22 million. Fortrea had a negative net margin of 36.21% and a positive return on equity of 6.23%. On average, analysts expect Fortrea to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fortrea Stock Up 0.2%

Shares of NASDAQ FTRE traded up $0.02 during midday trading on Monday, hitting $12.20. 323,575 shares of the stock traded hands, compared to its average volume of 1,530,672. The company has a market cap of $1.15 billion, a PE ratio of -1.12, a P/E/G ratio of 0.45 and a beta of 1.92. Fortrea has a one year low of $3.97 and a one year high of $18.67. The business has a 50 day moving average price of $9.88 and a two-hundred day moving average price of $12.46. The company has a debt-to-equity ratio of 1.86, a quick ratio of 0.98 and a current ratio of 0.98.

Insider Buying and Selling

In other Fortrea news, CFO Jill G. Mcconnell sold 5,061 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of $9.07, for a total value of $45,903.27. Following the completion of the sale, the chief financial officer owned 69,796 shares in the company, valued at approximately $633,049.72. This trade represents a 6.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In the last ninety days, insiders have sold 9,673 shares of company stock valued at $92,242. Company insiders own 0.38% of the company’s stock.

Institutional Investors Weigh In On Fortrea

Large investors have recently modified their holdings of the stock. Osaic Holdings Inc. increased its stake in shares of Fortrea by 74.3% during the 2nd quarter. Osaic Holdings Inc. now owns 6,844 shares of the company’s stock worth $38,000 after purchasing an additional 2,918 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Fortrea by 137.0% during the 2nd quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company’s stock worth $43,000 after purchasing an additional 5,036 shares during the last quarter. Toronto Dominion Bank purchased a new stake in shares of Fortrea during the 4th quarter worth approximately $51,000. EverSource Wealth Advisors LLC increased its stake in shares of Fortrea by 662.9% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 11,963 shares of the company’s stock worth $59,000 after purchasing an additional 10,395 shares during the last quarter. Finally, Franklin Resources Inc. purchased a new position in Fortrea in the 2nd quarter valued at approximately $60,000.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Fortrea in a report on Tuesday, April 21st. Truist Financial set a $22.00 target price on Fortrea and gave the company a “buy” rating in a research report on Thursday, January 8th. Mizuho set a $15.00 price target on Fortrea in a research report on Friday, January 9th. Evercore set a $25.00 price objective on Fortrea and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Finally, Robert W. Baird reduced their target price on shares of Fortrea from $19.00 to $16.00 and set an “outperform” rating for the company in a research note on Friday, February 27th. Five investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $16.05.

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.